Virax Biolabs Group Limited (VRAX)
NASDAQ·Healthcare·Biotechnology
$0.79
-33.45%
Mkt Cap $1.61M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.00
Range $1.00 – $1.00
Implied Upside
+27.3%
Consensus $1.00 vs current $0.79
NASDAQ·Healthcare·Biotechnology
$0.79
-33.45%
Mkt Cap $1.61M
No recent rating data.
Price Target (1 analysts)
$1.00
Range $1.00 – $1.00
+27.3%
Consensus $1.00 vs current $0.79